# Safety Study of Hepatitis E Vaccine (HEV239)

> **NCT03827395** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 25 (actual)

## Conditions studied

- Hepatitis E
- Immunisation

## Interventions

- **BIOLOGICAL:** HEV 239
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03827395
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-12
- **Primary completion:** 2020-08-28
- **Final completion:** 2020-08-28
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2021-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03827395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03827395, "Safety Study of Hepatitis E Vaccine (HEV239)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03827395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*